The White House has announced its intent to appoint the following experts to the President’s Cancer Panel, which advises the president of the United States on barriers to progress in reducing the burden of cancer:
After the stunning success of mRNA vaccines during the COVID-19 pandemic, researchers and biotech companies are racing to prove the utility of the technology in an array of non-communicable diseases—including cancer, cystic fibrosis, and sickle cell disease.
